| Search for the keyword: | |
| Indications for dabigatran etexilate |
| source:Vitalpharms Company Ltd. Release date:2021-9-15 9:05:22 |
| This product is used to prevent stroke and systemic embolism (SEE) in adult patients with non-valvular atrial fibrillation who have one or more of the following risk factors: 1. Previous stroke, transient ischemic attack or systemic embolism. 2. Left ventricular ejection fraction <40%. 3. Symptomatic heart failure, New York Heart Association (NYHA) heart function classification ≥2. 4. Age ≥75 years old. 5. Age ≥65 years old and accompanied by any of the following diseases: diabetes, coronary heart disease or hypertension. |
| Next:Apixaban usage and dosage |
